Health & pharma news, latest stories & analysis

Find today's trending Health & pharma news & headlines

AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for cancer therapy
  • AbbVie has acquired ImmunoGen for $10.1 billion in cash, it announced recently.
  • Integrating ImmunoGen's Elahere may be a pivotal step for AbbVie to offset Humira's declining exclusivity.
  • The acquisition is set to finalise by mid-2024.
December 1, 2023
Eli Lilly, Novo Nordisk to benefit as Pfizer’s weight loss drug implodes
December 1, 2023

Trending news

Trading ideas & analysis

Cassava Sciences: SAVA stock plot thickens, short interest jumps
October 13, 2023
TG Therapeutics (TGTX) stock price has plunged: buy the dip?
October 11, 2023
Cassava Sciences (SAVA) stock price forms a bullish pattern: is it a buy?
October 5, 2023
Featured by Invezz

How to protect your crypto from hacks, bull market trend confirmed
NVOS stock price is surging but Novo Integrated is still risky
Acadia stock price analysis: ACAD risk/reward is attractive
TTOO stock price outlook as big shareholder dumps shares
Featured by Invezz

How to protect your crypto from hacks, bull market trend confirmed
IOVA stock price soared but risk/reward is unfavourable for now

More breaking stories
Cigna may soon merge with Humana: report
Cigna may soon merge with Humana: report November 29, 2023
RedHill Biopharma (RDHL) gained 216% after FDA approvals: Buy Now!
RedHill Biopharma (RDHL) gained 216% after FDA approvals: Buy Now! November 28, 2023
Biodexa (BDRX) gained 91% in a single day: should you buy?
Biodexa (BDRX) gained 91% in a single day: should you buy? November 28, 2023
Mounjaro is more effective for weight loss than Ozempic: study reveals
Mounjaro is more effective for weight loss than Ozempic: study reveals November 27, 2023

5 states host nearly half of America’s largest private companies
5 states host nearly half of America’s largest private companies November 22, 2023
Tenet Healthcare to sell three of its hospitals to Novant Health
Tenet Healthcare to sell three of its hospitals to Novant Health November 17, 2023
Crispr Therapeutics (CRSP) stock price is on the cusp of a 25% pop
Crispr Therapeutics (CRSP) stock price is on the cusp of a 25% pop November 16, 2023
Ginkgo Bioworks (DNA): Insiders are selling Cathie Wood-backed stock
Ginkgo Bioworks (DNA): Insiders are selling Cathie Wood-backed stock November 14, 2023

Pfizer stock dips as Swiss Biotech Basilea secures rights to Fosmanogepix
Pfizer stock dips as Swiss Biotech Basilea secures rights to Fosmanogepix November 13, 2023
Eli Lilly’s Tirzepatide approved in the EU days after US and UK approval
Eli Lilly’s Tirzepatide approved in the EU days after US and UK approval November 10, 2023
Cano Health stock price analysis: Bankruptcy risks are elevated
Cano Health stock price analysis: Bankruptcy risks are elevated November 10, 2023
3M (MMM) stock declines after company’s leadership changes
3M (MMM) stock declines after company’s leadership changes November 9, 2023

Are Germany’s manufacturing and construction sectors starting to unravel?
Are Germany’s manufacturing and construction sectors starting to unravel? November 7, 2023
Insulet (PODD) stock up 14% on positive earnings and growth forecast
Insulet (PODD) stock up 14% on positive earnings and growth forecast November 3, 2023
Novavax could become a penny stock: beware of the Wyckoff theory
Novavax could become a penny stock: beware of the Wyckoff theory November 3, 2023
Wider-than-expected losses see Peloton stock price dip in pre-market
Wider-than-expected losses see Peloton stock price dip in pre-market November 2, 2023

DaVita stock price forecast: Ozempic sell-off is an overreaction
DaVita stock price forecast: Ozempic sell-off is an overreaction October 25, 2023
1 3 … 78

Other topics

Alternative Investment
Bond Market
Commodity
Crypto
Economic
Features
Forex
Personal Finance
Press Releases
Real Estate
Stock Market
Trading Ideas
Video
World